Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 8.01, 9.01 · 8-K

eXoZymes Inc.

EXOZNASDAQEQUITYCurrent

Other Events

Item 8.01 Other Events. The Company determined to hold its 2026 annual meeting on November 13, 2026, and plans to distribute its proxy statement and proxy to the shareholders on or about September 28, 2026. The record date for the meeting was September 15, 2026.

Filed Sep 18, 2026Accepted Sep 18, 2026, 1:24 PM EDTCIK 2010788Accession 0001493152-26-043288
Share

Company context

Current securities

Historical securities (1)

Recent company filings

  1. 10-Q filingAug 13, 2026
  2. Entry into a Material Definitive AgreementJul 1, 2026
  3. 424B5 filingJun 30, 2026
  4. Regulation FD DisclosureJun 26, 2026
  5. Entry into a Material Definitive Agreement · Regulation FD DisclosureJun 17, 2026

Registered securities in this filing

EXOZYMES INC. · 8-K · Filed 2026-09-18

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol
EXOZ
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: AsOf2026-09-17

Dimensions: Not supplied

Accession 000149315226043288 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. The Company determined to hold its 2026 annual meeting on November 13, 2026, and plans to distribute its proxy statement and proxy to the shareholders on or about September 28, 2026. The record date for the meeting was September 15, 2026.